Efficacy of bortezomib in combination chemotherapy on secondary plasma cell leukemia
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10428190701370597
Reference15 articles.
1. Bortezomib is effective in primary plasma cell leukemia
2. Novel biological therapies for the treatment of multiple myeloma
3. Perspectives for combination therapy to overcome drug-resistant multiple myeloma
4. Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
5. Proteasome inhibitor bortezomib for the treatment of multiple myeloma
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bortezomib-based Regimens Improve Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study;Turkish Journal of Hematology;2019-11-26
2. Primary Plasma Cell Leukemia: Identity Card 2016;Current Treatment Options in Oncology;2016-03-19
3. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party;Annals of Oncology;2012-06
4. Primary plasma cell leukemia in the era of new drugs: Has something changed?;Critical Reviews in Oncology/Hematology;2012-05
5. Plasma cell leukaemia and other aggressive plasma cell malignancies;British Journal of Haematology;2010-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3